12.5/1000 322M (Kazano 12.5 mg / 1000 mg)
Generic Name: alogliptin/metformin
Pill with imprint 12.5/1000 322M is Yellow, Elliptical/Oval and has been identified as Kazano 12.5 mg / 1000 mg. It is supplied by Takeda Pharmaceuticals America, Inc.
Kazano is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Kazano 12.5 mg / 1000 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 12.5/1000 322M
Kazano
- Generic Name
- alogliptin/metformin
- Imprint
- 12.5/1000 322M
- Strength
- 12.5 mg / 1000 mg
- Color
- Yellow
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Takeda Pharmaceuticals America, Inc.
- Inactive Ingredients
-
mannitol,
microcrystalline cellulose,
magnesium stearate,
magnesium silicate,
titanium dioxide,
ferric oxide yellow,
hypromellose 2910 (6 mPa.s)
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 64764-0337 | Takeda Pharmaceutical Company Limited |
| 45802-0211 | Perrigo Company |
Related images for "12.5/1000 322M"
More about Kazano (alogliptin / metformin)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (1)
- Drug images
- Pricing & coupons
- En español
- Drug class: antidiabetic combinations
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.